tiprankstipranks
Trending News
More News >
Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market
Advertisement

Aziyo Biologics (ELUT) Technical Analysis

Compare
66 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Aziyo Biologics’s (ELUT) Moving Averages Convergence Divergence (MACD) indicator is 0.09, suggesting Aziyo Biologics is a Sell.
Aziyo Biologics’s (ELUT) 20-Day exponential moving average is 2.08, while Aziyo Biologics’s (ELUT) share price is $2.05, making it a Sell.
Aziyo Biologics’s (ELUT) 50-Day exponential moving average is 2.07, while Aziyo Biologics’s (ELUT) share price is $2.05, making it a Sell.

Aziyo Biologics (ELUT) Pivot Points

Jul 16, 2025, 07:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.52
1.78
1.91
2.18
2.31
2.57
2.70
Fibonacci
1.78
1.93
2.02
2.18
2.33
2.42
2.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aziyo Biologics (ELUT) Moving Averages

Jul 16, 2025, 07:16 PM
Period
Simple
Exponential
MA5
2.27Sell
2.15Sell
MA10
2.21Sell
2.15Sell
MA20
2.02Sell
2.08Sell
MA50
1.91Buy
2.07Sell
MA100
2.31Sell
2.31Sell
MA200
2.96Sell
2.84Sell
Aziyo Biologics’s (ELUT) 10-Day exponential moving average is 2.15, while Aziyo Biologics’s (ELUT) share price is $2.05, making it a Sell.
Aziyo Biologics’s (ELUT) 100-Day exponential moving average is 2.31, while Aziyo Biologics’s (ELUT) share price is $2.05, making it a Sell.
Aziyo Biologics’s (ELUT) stock price is $2.05 and Aziyo Biologics’s (ELUT) 50-day simple moving average is 1.91, creating a Buy signal.
Aziyo Biologics’s (ELUT) stock price is $2.05 and Aziyo Biologics’s (ELUT) 100-day simple moving average is 2.31, creating a Sell signal.
Aziyo Biologics’s (ELUT) stock price is $2.05 and Aziyo Biologics’s (ELUT) 200-day simple moving average is 2.96, creating a Sell signal.

Aziyo Biologics (ELUT) Technical Indicators

Jul 16, 2025, 07:16 PM
Name
Value
Implied Action
RSI (14)
47.23
Neutral
STOCH (9,6)
26.97
Neutral
STOCHRSI (14)
46.30
Neutral
MACD (12,26)
0.09
Sell
ADX (14)
24.90
Neutral
Williams %R
-71.74
Buy
CCI (14)
14.38
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
37.62
Neutral
ROC
14.45
Buy
Aziyo Biologics’s (ELUT) Relative Strength Index (RSI) is 47.23, creating a Neutral signal.
Aziyo Biologics’s (ELUT) Trend Strength Indicator (ADX) is 24.90, creating a Neutral signal.
Aziyo Biologics’s (ELUT) Commodity Channel Index (CCI) is 14.38, creating a Neutral signal.
Aziyo Biologics’s (ELUT) Price Rate of Change (ROC) is 14.45, creating a Buy signal.

FAQ

Is ELUT a Buy, Hold, or Sell?
Based on ELUT’s technical indicators, ELUT is a Sell.
    What is ELUT’s RSI (14)?
    ELUT’s RSI (14) is 47.23, which suggests ELUT is a Neutral.
      What is ELUT’s MACD?
      ELUT’s MACD is 0.09, which suggests ELUT is a Sell.
        What is ELUT’s 5-day moving average?
        ELUT’s 5-day moving average is 2.27, which suggests ELUT is a Sell.
          What is ELUT’s 20-day moving average?
          ELUT 20-day moving average is 2.02, which suggests ELUT is a Sell.
            What is ELUT’s 50-day moving average?
            ELUT’s 50-day moving average is 1.91, which suggests ELUT is a Buy.
              What is ELUT’s 200-day moving average?
              ELUT’s 200-day moving average is 2.96, which suggests ELUT is a Sell.
                What is ELUT’s Williams % R (14)?
                ELUT’s Williams % R (14) is -71.74, which suggests ELUT is a Buy.
                  What is ELUT’s CCI (14)?
                  ELUT’s CCI (14) is 14.38, which suggests ELUT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis